Eli Lily

Thumbnail for Eli Lilly invests US$10M in Organovo’s FXR Agonist for IBD development

26 February 2025

Eli Lilly invests US$10M in Organovo’s FXR Agonist for IBD development

Thumbnail for Eli Lilly invests up to US$630M in OliX’s RNAi-based MASH drug

14 February 2025

Eli Lilly invests up to US$630M in OliX’s RNAi-based MASH drug

Thumbnail for FDA approves Tirzepatide for obstructive sleep apnea in Adults with obesity

16 January 2025

FDA approves Tirzepatide for obstructive sleep apnea in Adults with obesity

Thumbnail for Mediar Therapeutics licenses IPF therapy to Eli Lilly

15 January 2025

Mediar Therapeutics licenses IPF therapy to Eli Lilly

Thumbnail for Eli Lilly to open New Global Capability Centre in Hyderabad, India

15 January 2025

Eli Lilly to open New Global Capability Centre in Hyderabad, India

Thumbnail for Eli Lilly to invest US$3B in expanding Wisconsin manufacturing facility

8 December 2024

Eli Lilly to invest US$3B in expanding Wisconsin manufacturing facility

Thumbnail for Moeller joins Lilly Board, Walker to step down

20 November 2024

Moeller joins Lilly Board, Walker to step down

Thumbnail for King Faisal Specialist Hospital & Research Centre patrners with Eli Lilly Partner to advance Alzheimer’s care in Saudi Arabia

7 November 2024

King Faisal Specialist Hospital & Research Centre patrners with Eli Lilly Partner to advance Alzheimer’s care in Saudi Arabia

Thumbnail for Eli Lilly invests US$2B in two manufacturing plants in Ireland

12 September 2024

Eli Lilly invests US$2B in two manufacturing plants in Ireland

Thumbnail for Eli Lilly names new CFO, expands healthcare access in Africa

10 September 2024

Eli Lilly names new CFO, expands healthcare access in Africa